After leading the company for six years, Robert Bazemore is stepping down as chief executive officer (CEO) of Epizyme. On Monday, the Cambridge, Mass.-based company announced that industry veteran Grant Bogle has taken over as president and CEO.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,